Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Radiother Oncol. 2020 Apr 27;149:64–69. doi: 10.1016/j.radonc.2020.04.038

Table 4 —

Distribution of 4-year PSA levels in primary cohort according to risk grouping.

PSA Level, ng/mL Favorable Risk Intermediate Risk High Risk P Value
≤0.2 2738 (75%) 3383 (77%) 578 (82%) <0.00001
>0.2 – ≤0.5 573 (16%) 516 (12%) 39 (6%) <0.00001
>0.5 – ≤1.0 194 (5%) 232 (5%) 29 (4%) 0.000126
>1.0 156 (4%) 248 (6%) 60 (9%) <0.00001